Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1(SF-2) recombinant GP120. (Q45738849)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2001

Language	Label	Description	Also known as
English	Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1(SF-2) recombinant GP120.	scientific article published in February 2001

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1(SF-2) recombinant GP120. (English)

1 reference

Europe PubMed Central

15 December 2017

Canarypox virus

object named as

canarypox virus

1 reference

based on heuristic

inferred from title

Geoffrey J Gorse

1

object named as

G J Gorse

1 reference

Europe PubMed Central

15 December 2017

Robert B Belshe

6

object named as

R B Belshe

1 reference

Europe PubMed Central

15 December 2017

2

object named as

G B Patel

1 reference

Europe PubMed Central

15 December 2017

author name string

M D Mandava

3

1 reference

Europe PubMed Central

15 December 2017

J A Arbuckle

4

1 reference

Europe PubMed Central

15 December 2017

T M Doyle

5

1 reference

Europe PubMed Central

15 December 2017

National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

7

1 reference

Europe PubMed Central

15 December 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

19

1 reference

Europe PubMed Central

15 December 2017

13-14

1 reference

Europe PubMed Central

15 December 2017

1806-1819

1 reference

Europe PubMed Central

15 December 2017

Cytokine patterns during the progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Th1-Th2 hypothesis of HIV infection: new insights

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel features of the respiratory tract T-cell response to influenza virus infection: lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus (HIV-1) gp160-specific lymphocyte proliferative responses of mononuclear leukocytes from HIV-1 recombinant gp160 vaccine recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Human interleukin-12 enhances interferon-gamma-producing influenza-specific memory CD8+ cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Th1/Th2 cytokine responses following HIV-1 immunization in seronegative volunteers. The AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of intracellular antigen-specific cytokines in human T cell populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus-specific IFNγ and IL-4 are produced by antigen expanded human blood lymphocytes from seropositive volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotypic and functional separation of memory and effector human CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokines and infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of Type 1 and Type 2 Cytokines in HIV Type 1-Infected Individuals: Impact of Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV versus cytotoxic T lymphocytes--the war being lost

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of a polyclonal cytolytic T lymphocyte response to human immunodeficiency virus in persons without clinical progression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Persisting human immunodeficiency virus type 1 gp160-specific human T lymphocyte responses including CD8+ cytotoxic activity after receipt of envelope vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization, and quantitation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Human CD4+ cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900378-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(00)00378-9

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45738849&oldid=1680540752"